Follow
Qingquan Chen
Title
Cited by
Cited by
Year
The safety and toxicity of phage therapy: a review of animal and clinical studies
D Liu, JD Van Belleghem, CR de Vries, E Burgener, Q Chen, ...
Viruses 13 (7), 1268, 2021
1402021
Pyoverdine-Dependent Virulence of Pseudomonas aeruginosa Isolates From Cystic Fibrosis Patients
D Kang, AV Revtovich, Q Chen, KN Shah, CL Cannon, NV Kirienko
Frontiers in microbiology 10, 2048, 2019
952019
Pf bacteriophage and their impact on Pseudomonas virulence, mammalian immunity, and chronic infections
PR Secor, EB Burgener, M Kinnersley, LK Jennings, V Roman-Cruz, ...
Frontiers in immunology 11, 244, 2020
802020
Antimicrobial activity of ibuprofen against cystic fibrosis-associated gram-negative pathogens
PN Shah, KR Marshall-Batty, JA Smolen, JA Tagaev, Q Chen, ...
Antimicrobial agents and chemotherapy 62 (3), 10.1128/aac. 01574-17, 2018
522018
A filamentous bacteriophage protein inhibits type IV pili to prevent superinfection of Pseudomonas aeruginosa
AK Schmidt, AD Fitzpatrick, CM Schwartzkopf, DR Faith, LK Jennings, ...
MBio 13 (1), e02441-21, 2022
302022
Bacteriophage and bacterial susceptibility, resistance, and tolerance to antibiotics
Q Chen, T Dharmaraj, PC Cai, EB Burgener, NL Haddock, AJ Spakowitz, ...
Pharmaceutics 14 (7), 1425, 2022
242022
Minocycline and Silver Dual-Loaded Polyphosphoester-Based Nanoparticles for Treatment of Resistant Pseudomonas aeruginosa
Q Chen, KN Shah, F Zhang, AJ Salazar, PN Shah, R Li, JC Sacchettini, ...
Molecular pharmaceutics 16 (4), 1606-1619, 2019
222019
Filamentous bacteriophage delays healing of Pseudomonas-infected wounds
MS Bach, CR de Vries, A Khosravi, JM Sweere, MC Popescu, Q Chen, ...
Cell reports Medicine 3 (6), 2022
172022
Phages in vaccine design and immunity; mechanisms and mysteries
CR de Vries, Q Chen, S Demirdjian, G Kaber, A Khosravi, D Liu, ...
Current opinion in biotechnology 68, 160-165, 2021
172021
Pf bacteriophage and their impact on Pseudomonas virulence, mammalian immunity, and chronic infections. Front Immunol 11: 244
PR Secor, EB Burgener, M Kinnersley, LK Jennings, V Roman-Cruz, ...
82020
A filamentous bacteriophage protein inhibits type IV pili to prevent superinfection of Pseudomonas aeruginosa. mBio 13: e02441-21
AK Schmidt, AD Fitzpatrick, CM Schwartzkopf, DR Faith, LK Jennings, ...
72022
N-acetyl cysteine abrogates silver-induced reactive oxygen species in human cells without altering silver-based antimicrobial activity
KN Shah, PN Shah, AR Mullen, Q Chen, MR Southerland, B Chirra, ...
Toxicology letters 332, 118-129, 2020
62020
Hetero-Multivalent Targeted Liposomal Drug Delivery to Treat Pseudomonas aeruginosa Infections
A Singla, SB Simbassa, B Chirra, A Gairola, MR Southerland, KN Shah, ...
ACS Applied Materials & Interfaces 14 (36), 40724-40737, 2022
52022
A filamentous bacteriophage protein inhibits type IV pili to prevent superinfection of Pseudomonas aeruginosa. mBio 13: e0244121
AK Schmidt, AD Fitzpatrick, CM Schwartzkopf, DR Faith, LK Jennings, ...
52022
Filamentous bacteriophages and the competitive interaction between Pseudomonas aeruginosa strains under antibiotic treatment: a modeling study
JD Pourtois, MJ Kratochvil, Q Chen, NL Haddock, EB Burgener, ...
Msystems 6 (3), 10.1128/msystems. 00193-21, 2021
52021
Rapid assessment of changes in phage bioactivity using dynamic light scattering
T Dharmaraj, MJ Kratochvil, JD Pourtois, Q Chen, M Hajfathalian, A Hargil, ...
PNAS nexus 2 (12), pgad406, 2023
32023
BACTERIA-SPECIFIC DRUG DELIVERY: HETERO-MULTIVALENT TARGETED LIPOSOMES FOR TREATMENT OF PSEUDOMONAS AERUGINOSA
SB Simbassa, A Singla, KN Shah, Q Chen, B Chirra, N Dangol, R Raina, ...
PEDIATRIC PULMONOLOGY 54, S266-S267, 2019
12019
Antimicrobial activity of a natural compound and analogs against multi-drug-resistant Gram-positive pathogens
KN Shah, PN Shah, FO Agobe, K Lovato, H Gao, O Ogun, C Hoffman, ...
Microbiology Spectrum, e01515-22, 2024
2024
Pf bacteriophages hinder sputum antibiotic diffusion via electrostatic binding
Q Chen, P Cai, THW Chang, E Burgener, MJ Kratochvil, A Gupta, A Hargil, ...
bioRxiv, 2024.03. 10.584330, 2024
2024
Synergistic Antimicrobial Effects of Ibuprofen Combined with Standard-of-Care Antibiotics against Cystic Fibrosis Pathogens
Q Chen, M Ilanga, SB Simbassa, B Chirra, KN Shah, CL Cannon
Biomedicines 11 (11), 2936, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20